Skip to main content
Signal8

Immuron Ltd (IMRN) Form 6-K — Nov 18, 2026

$IMRNForm 6-KFiled Nov 18, 2026, 8:00 AM ET0001213900-26-121612Original filing

Immuron reported FY26 global sales revenue of AUD $7.7 million, up 6%, with net loss narrowing to AUD $(3.8) million and cash of AUD $9.0 million. FY27 year-to-date October revenue is up 10% globally, though U.S. sales are down 19% while Canada is up 150%. At the 2026 AGM, shareholders passed the remuneration report and re-elected Dr Jeannette Joughin, but rejected resolutions on increased placement capacity, the omnibus incentive plan, and a non-board-endorsed candidate.

Key figures

Revenue
AUD $7.7m FY26 global sales revenue
Net Income
AUD $(3.8)m net profit (improved $1.4m)
Revenue Yoy
Up 6%
Cash Position
AUD $9.0m
Fy26 us revenue
AUD $1.8m (up 7% USD)
Fy26 gross margin
64.5% (0.9% decline)
Fy26 australia revenue
AUD $5.8m (up 10%)
Fy27 ytd oct global revenue
AUD $3.0m (up 10%)
Fy27 ytd usa revenue change
down 19%
Imm529 peak sales estimate us
US$400 million (Lumanity estimate)
Fy27 ytd canada revenue change
up 150%
Remuneration report against vote
43.58%
Placement capacity resolution failed
65.62% against

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.